Arcutis Gets FDA Nod for Topical Foam - San Fernando Valley Business Journal

Westlake Village-based immuno-dermatology company Arcutis Biotherapeutics Inc. has received approval from the Food and Drug Administration for a topical foam version of its main drug to treat seborrheic dermatitis in individuals aged 9 and older.

Related Keywords

United States ,Frank Watanabe ,Arcutis Biotherapeutics Inc ,Drug Administration ,Westlake Village Based ,